- Home
- LANV vs CRVO Comparison
LANV vs CRVO Comparison
Compare LANV & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LANV | CRVO |
|---|---|---|
| Founded | 2015 | 2001 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.0M | 89.1M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LANV | CRVO |
|---|---|---|
| Price | $1.70 | $7.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $21.50 |
| AVG Volume (30 Days) | 46.4K | ★ 61.3K |
| Earning Date | 08-29-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $341,783,911.00 | $6,159,786.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6.90 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.38 | $1.87 |
| 52 Week High | $2.69 | $16.94 |
Technical Indicators
Market Signals| Indicator | LANV | CRVO |
|---|---|---|
| Relative Strength Index (RSI) | 31.30 | 41.56 |
| Support Level | $1.60 | $7.61 |
| Resistance Level | $2.30 | $8.55 |
| Average True Range (ATR) | 0.18 | 0.59 |
| MACD | -0.04 | -0.15 |
| Stochastic Oscillator | 4.29 | 6.42 |
Price Performance
Historical ComparisonAbout LANV Lanvin Group Holdings Limited
Lanvin Group Holdings Ltd engages in offering products ranging from apparel to leather goods, footwear, and accessories. The firm is operating mainly 5 portfolio brands, namely Lanvin, Wolford, Sergio Rossi, St. John, and Caruso. It derives the majority of its revenue from the Wolford segment.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.